下静脉卡瓦过器:临床审查和未来的前景
Raffaella Benedetti1, Simone Marino2, Flavio Tangianu2
1Haemostasis and Thrombosis Center, Department of Internal Medicine, Hospital of Piacenza, 29121 Piacenza, Italy.
Journal of clinical medicine
|March 28, 2024
概括
下腔静脉 (IVC) 过器为静脉血栓塞栓症 (VTE) 提供了抗凝药的替代方案,当抗凝药是禁忌时. 为了确定适当的IVC过器使用和及时检索以尽量减少并发症,一个多学科的方法至关重要.
科学领域:
- 血管外科 血管外科
- 干预性放射学 干预性放射学
- 血液学 血液学 血液学
背景情况:
- 抗凝药是静脉血栓塞栓症 (VTE) 的主要治疗方法.
- 下腔静脉 (IVC) 过器是当抗凝药是禁忌时的替代方案.
- 讨论了IVC过器除了抗凝药的禁忌之外的使用指示.
研究的目的:
- 讨论IVC过器在VTE管理中的作用.
- 为了突出永久和可检索过器的可用性.
- 强调IVC过器管理多学科方法的重要性.
主要方法:
- 关于IVC过器使用的当前临床实践和文献的审查.
- 讨论说明,过器类型 (永久性或可检索) 和并发症.
- 强调需要专家共识和针对患者的具体决策.
主要成果:
- IVC过器可以防止下肢栓塞进入肺循环.
- 可取回过器提供临时保护,并且可以被移除.
- 永久性或长期存在的过器会引起并发症.
结论:
- 插入IVC过器是一种可行的策略,用于VTE,当抗凝固是不可行的.
- 适当的选择和检索时间对于优化结果至关重要.
- 多学科的团队方法确保了 caval 过器治疗的最佳管理.
相关概念视频
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
377
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
377
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
414
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
414
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
469
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
469
Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
749
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
749
Hemodialysis I: Introduction
4.0K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
4.0K


